By promoting the virus infected breast cancer cell lines to increasingly enter S and G2 phases in the presence of measurable DNA damage, potentially indicates the ability of AAV2 to interfere with Chk1 kinase functions. The gene discussed is CHEK1; the disease is breast cancer.